AHF and Society for AIDS in Africa Convene High-Level Summit to Advance Regional Health Leadership and Sustainable Health Financing in Africa at ICASA 2025 The AIDS Healthcare Foundation (AHF) Global…
Corstasis Partners with Cardiovascular Logistics to Redefine Heart Failure Treatment Corstasis Therapeutics Inc., a commercial-stage biopharmaceutical company focused on advancing patient-centric, outpatient treatment strategies for cardiovascular and renal disorders, today…
Otsuka Announces FDA Accelerated Approval of VOYXACT® for Proteinuria Reduction in Adults with Primary IgA Nephropathy Otsuka Pharmaceutical Development & Commercialization, Inc., together with Otsuka Pharmaceutical Co., Ltd., announced that…
Arrowhead Pharmaceuticals Reports Fiscal Year 2025 Financial Results and Highlights Major Regulatory and Clinical Milestones Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its financial results for the fiscal year ending…
Real-World Study Shows Durable Cardiovascular Protection with Repatha Target RWE, a leading organization in modern real-world evidence (RWE) generation and a trusted partner for regulatory-grade research, has announced significant new…
EdgeOne Medical Appoints Industry Veteran Marty Shelton as Chief Operating Officer to Advance Operational Excellence, Client Value, and Long-Term Growth EdgeOne Medical, a trusted provider of development and testing services…
Allurion Unveils Initial Results on Program + Tirzepatide Combo Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR)—a global leader in innovative, non-surgical weight-loss technology—today announced encouraging initial results from…
PrimeStore® MTM Shows Strong Validation for Global TB Testing Longhorn Vaccines & Diagnostics (“Longhorn”), a One Health-focused biotechnology company advancing innovative diagnostics and antibody platforms to address global public health…
ReAlta Life Sciences Strengthens Leadership Team with Appointment of Dr. Howard Berman as Executive Chairman ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company pioneering next-generation medicines…
Zetagen Therapeutics Announces Oversubscribed $12.9M Series B1 Financing to Advance Breakthrough Intratumoral Therapies for Breast Cancer Zetagen Therapeutics, Inc., a privately held clinical-stage biopharmaceutical company advancing first-in-class intratumoral therapies for…
Enigma Biomedical USA Awarded $2 Million Grant from The Michael J. Fox Foundation to Advance Novel α-Synuclein PET Imaging Biomarker for Parkinson’s Disease Enigma Biomedical USA (EB USA) today announced…
Vyome Holdings Announces Appointment of Renowned Oncologist Dr. Aditya Bardia as Senior Medical Advisor to Advance VT-1953 for Malignant Fungating Wounds Vyome Holdings, Inc. (“Vyome”) (NASDAQ: HIND), a clinical-stage healthcare…